Abstract:Objective:To explore the risk factors of coronary slow flow(CSF)and the role of inflammatory response on its pathogenesis.Methods:The CSF was evaluated by corrected thrombolysis in myocardial infarction(TIMI)frame count (CTFC).Totally 96 cases with CSF(CSF group)and 106 cases with normal flow(NCSF group)were selected from patients undergoing coronary angiography(CAG)in our hospital from January 2016 to December 2016.Single and multi-variable logistic regression analysis was used to assess the relationship between CSF and clinical characteristics,baseline biochemistry and related inflammation factors(both in peripheral venous blood and in coronary arterial blood)including interleukin-6(IL-6), hypersensitive C reactive protein(hsCRP)and matrix metalloproteinase-9(MMP-9).Results:The CTFC values of three branches of coronary arteria in CSF group were all significantly higher than those in control group(left anterior descending:32.3 ± 3.7 vs 17.8 ± 2.1,left circumflex branch:34.5 ± 3.9 vs 23.1 ± 2.8,right coronary artery:34.9 ± 4.3 vs 21.4 ± 3.2, all P<0.01).The most common coronary artery involved by CSF was right coronary artery(83.3%).Single factor analysis found that the body mass index,diabetes ratio,uric acid,IL-6,hsCRP in coronary arterial blood,MMP-9 in both peripheral venous and coronary arterial blood in CSF group were significantly higher than those in NCSF group(P< 0.05 or 0.01). Logistic regression analysis found that body mass index(OR= 1.313,95% CI 1.026-1.654,P= 0.034),diabetes(OR=1.604,95% CI 1.198-2.466,P=0.006),uric acid(OR=1.036,95% CI 1.006-1.102,P= 0.027),M M P-9 in peripheral venous blood(OR=2.279,95% CI 1.478-4.022,P=0.004),M M P-9 in involved coronary arterial blood(OR=3.145,95%CI 2.011-5.023,P=0.000)were independent risk factors of CSF.Conclusions:Body mass index,diabetes,and uric acid are independent risk factors of CSF.Compared with the systemic inflammatory response,local inflammatory response of the involved coronary arteries is more relevant to CSF.MMP-9 plays an important role in the pathogenesis of CSF.

Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?

Association Between Systemic Inflammation Response Index and Slow Coronary Flow Phenomenon in Patients with Ischemia and No Obstructive Coronary Arteries

The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients

Pan-Immune-Inflammatory Value is Superior to Other Inflammatory Indicators in Predicting Inpatient Major Adverse Cardiovascular Events and Severe Coronary Artery Stenosis after Percutaneous Coronary Intervention in STEMI Patients

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

Risk factors of coronary slow flow and its correlation with inflammatory response based on single clinical center in China

Plasma atherogenic indices are independent predictors of slow coronary flow

Increased Plasma C-reactive Protein and Interleukin-6 Concentrations in Patients with Slow Coronary Flow.

Neutrophil Percentage to Albumin Ratio as a Predictor for Coronary Slow Flow Phenomenon in Patients with Myocardial Ischemia with No Obstructive Coronary Arteries

Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction

Association between the pan-immune-inflammation value and coronary collateral circulation in chronic total coronary occlusive patients

Pan-immune-inflammation value predict delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage

Association of Coronary Inflammation with Plaque Vulnerability and Fractional Flow Reserve in Coronary Artery Disease

Analysis of correlative factors of female coronary slow-flow phenomenon: A retrospective study

Portal Vein Pulsatility Index as a Potential Risk of Venous Congestion Assessed by Magnetic Resonance Imaging: A Prospective Study on Healthy Volunteers

Pan-Immune-Inflammatory Value Predicts the 3 Months Outcome in Acute Ischemic Stroke Patients after Intravenous Thrombolysis

Assessment of the Relationship Between Plasma Fibrinogen-to-albumin Ratio and Slow Coronary Flow Phenomenon in Patients Without Obstructive Coronary Artery Disease

A Preliminary Study of MMP-9 and Scd40l in Patients with Coronary Slow Flow.

Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever

What Is the Relationship Between Myocardial Perfusion Imaging and Coronary Artery Disease Risk Factors and Markers of Inflammation?

The pan immune inflammatory value in relation to non-alcoholic fatty liver disease and hepatic fibrosis